Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Novo Nordisk A/S Dexcom Inc Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Novo Nordisk A/S Politics
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Europe News Breaking News: Markets Breaking News: Europe
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Biotechnology Novo Nordisk A/S Companies
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Social issues Zealand Pharma A/S Healthy Returns
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Biotech and Pharmaceuticals LILLY DRN Business News
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Novo Nordisk A/S Vistra Corp Investing
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Biotech and Pharmaceuticals LILLY DRN Health & Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags U/S/ Economy US Economy Breaking News: Politics
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Business News Health & Science Pharmaceuticals
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Mobile Internet Health & Science
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Business Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Earnings LILLY DRN Health & Science
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotechnology Novo Nordisk A/S Europe Economy
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags LILLY DRN Health & Science Healthy Returns
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags stocks Business Amazon/com Inc
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Biotech and Pharmaceuticals Breaking News: Business Business
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Burberry Group PLC Europe Markets Retail
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Nutrition Medicare Social issues
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Pharmaceuticals Biotechnology Breaking News: Europe
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Healthy Returns Social issues Health & Science
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags LILLY DRN Pharmaceuticals Davos WEF
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Amazon/com Inc IQVIA Holdings Inc JPMorgan Chase & Co
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Social issues Business Abbvie Inc
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Zillow Group Inc Health care industry Cigna Corp
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Health & Science LILLY DRN Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags S&P 500 U/S/ Markets Mad Money
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.